Prevalence, clinical manifestation and mortality rate in COVID-19 patients with underlying diseases. (Special issue on COVID-19.) [Persian]

Sabet, M. N.; Khanalipour, M.; Gholami, M.; Sarli, A.; Khorrami, A. R.; Esmaeilzadeh, E.

Background and Aim: The new Coronavirus Disease 2019 (COVID-19) outbreak initiated from China in late December 2019, has posed a great global health threat. Since patients with high blood pressure, diabetes, and cardiovascular diseases are at high risk of COVID-19, this study aims to investigate the prevalence, severity, clinical manifestations, and mortality rate in COVID-19 patients with underlying diseases compared to those without underlying diseases. Methods & Materials: This study was performed on 1408 patients with COVID-19 admitted to Golestan, Hajar, Khanevadeh and Besat hospitals in Tehran, Iran. Required data including disease prevalence, severity, clinical manifestations and mortality rate in patients with and without underlying diseases were collected and then analyzed using statistical tests in SPSS software, considering a significance level of P<0.05. Ethical Considerations: This study was approved by the AJA University of Medical Sciences (Code: IR. AJAUMS. REC.1399.091). Ethical principles have been observed in accordance with the guidelines of the National Ethics Committee and the COPE regulations.